AMS - Family Medicine - Dermatology: Herpes Simplex and Zoster, Psoriasis, Systemic Diseases (Download)

Sale!

Original price was: $119.00.Current price is: $59.50.


Topics and Objectives

Title: Family Medicine – Dermatology: Herpes Simplex and Zoster, Psoriasis, Systemic Diseases
Faculty: O. Fred Miller, III, M.D., Michele S. Maroon, M.D.

Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

TOPIC 1: Herpes Simplex and Zoster; Lichen Planus.

Upon completion of this session, the participant should be able to: COMP, EBM

  1. Differentiate herpes simplex and herpes zoster based on morphology and distribution of lesions and laboratory testing.
  2. Analyze the varied manifestations, reactivation complications of herpes zoster as referenced in the 2011 Journal of Infectious Diseases.
  3. Determine an appropriate treatment plan for herpes simplex and herpes zoster as per 2011 FDA and Mayo proceedings recommendations.
  4. Evaluate the cutaneous spectrum of lichen planus.

TOPIC 2: Psoriasis.

Upon completion of this session, using AAD Guidelines for Psoriasis Therapy, the participant should be able to: EBM, GL, COMP

  1. Evaluate the spectrum of classical and subtle cutaneous changes of psoriasis.
  2. Formulate the basic pathophysiology of psoriasis.
  3. Approach topical psoriasis therapy with a basic algorithm.
  4. Develop a treatment plan based upon the AAD Guidelines for Management of Psoriasis and Psoriatic Arthritis and Use of Biologics, Phototherapy and Chemotherapy.

TOPIC 3: Dermatologic Manifestations of Systemic Disease.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Identify cutaneous markers of certain systemic diseases.
  2. Distinguish specific and nonspecific findings in relationship to underlying disease.
  3. Evaluate pruritus and differentiate those cases associated with systemic disease vs. primary cutaneous disease, including treatment of atopic dermatitis in accordance with AAD Guidelines.

StreamingINCLUDED
Total Cost: $

    Title: Family Medicine – Dermatology: Herpes Simplex and Zoster, Psoriasis, Systemic Diseases
    Faculty: O. Fred Miller, III, M.D., Michele S. Maroon, M.D.

    Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

    TOPIC 1: Herpes Simplex and Zoster; Lichen Planus.

    Upon completion of this session, the participant should be able to: COMP, EBM

    1. Differentiate herpes simplex and herpes zoster based on morphology and distribution of lesions and laboratory testing.
    2. Analyze the varied manifestations, reactivation complications of herpes zoster as referenced in the 2011 Journal of Infectious Diseases.
    3. Determine an appropriate treatment plan for herpes simplex and herpes zoster as per 2011 FDA and Mayo proceedings recommendations.
    4. Evaluate the cutaneous spectrum of lichen planus.

    TOPIC 2: Psoriasis.

    Upon completion of this session, using AAD Guidelines for Psoriasis Therapy, the participant should be able to: EBM, GL, COMP

    1. Evaluate the spectrum of classical and subtle cutaneous changes of psoriasis.
    2. Formulate the basic pathophysiology of psoriasis.
    3. Approach topical psoriasis therapy with a basic algorithm.
    4. Develop a treatment plan based upon the AAD Guidelines for Management of Psoriasis and Psoriatic Arthritis and Use of Biologics, Phototherapy and Chemotherapy.

    TOPIC 3: Dermatologic Manifestations of Systemic Disease.

    Upon completion of this session, the participant should be able to: EBM, GL, COMP

    1. Identify cutaneous markers of certain systemic diseases.
    2. Distinguish specific and nonspecific findings in relationship to underlying disease.
    3. Evaluate pruritus and differentiate those cases associated with systemic disease vs. primary cutaneous disease, including treatment of atopic dermatitis in accordance with AAD Guidelines.
    When you add a gift card to your CME purchase from American Medical Seminars:
    • The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
    • This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.